Prosecution Insights
Last updated: April 19, 2026

Examiner: EDWARDS, JESSICA FAYE

Tech Center 1600 • Art Units: 1657

This examiner grants 45% of resolved cases

Performance Statistics

45.2%
Allow Rate
-14.8% vs TC avg
80
Total Applications
+45.9%
Interview Lift
938
Avg Prosecution Days
Based on 42 resolved cases, 2023–2026

Rejection Statute Breakdown

10.2%
§101 Eligibility
14.0%
§102 Novelty
31.9%
§103 Obviousness
26.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17596422 ANTIBODY PURIFICATION METHODS AND COMPOSITIONS THEREOF Final Rejection Takeda Pharmaceutical Company LImited
17428009 EXERCISE-INDUCED CIRCULATORY FACTORS FOR AMELIORATION OF COGNITIVE, NEUROLOGICAL, AND REGENERATIVE DYSFUNCTION DURING AGING Non-Final OA The Regents of the University of California
18023130 METHOD FOR REMOVING ANTIFOAMING AGENTS FROM A FERMENTATION BROTH Final Rejection BASF SE
17558844 CELL CULTURE ARTICLE AND METHODS THEREOF Final Rejection CORNING INCORPORATED
17609137 MONITORING AND ALTERING THE GUT MICROBIOME IN DISEASE Final Rejection The General Hospital Corporation
18244685 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING EYE DISORDERS Non-Final OA MarvelBiome, Inc.
18256542 UPCYCLING MIXED WASTE PLASTIC THROUGH CHEMICAL DEPOLYMERIZATION AND BIOLOGICAL FUNNELING Non-Final OA Alliance for Sustainable Energy, LLC
18838967 PHOTOSYNTHETICALLY CONTROLLED SPIRULINA PRODUCTS WITH ENHANCED CONTENT AND/OR BIOAVAILABILITY OF UNOPPOSED, ACTIVE VITAMIN B12 Final Rejection Vaxa Technologeis Ltd.
17915903 CARBOHYDRATE BINDING MODULE VARIANTS Final Rejection Novozymes A/S
17781973 PROCESSES FOR PRODUCING FERMENTATION PRODUCTS Non-Final OA Novozymes A/S
18008364 NOVEL FAECALIBACTERIUM PRAUSNITZII STRAIN EB-FPDK9 AND USE THEREOF Final Rejection ENTEROBIOME INC.
18300789 METHODS FOR DETERMINING THE MOISTURE CONTENT OF THE SKIN Non-Final OA CHANEL PARFUMS BEAUTE
17434967 FERMENTATIVE PRODUCTION OF CARBOHYDRATES BY MICROBIAL CELLS UTILIZING A MIXED FEEDSTOCK Non-Final OA Chr Hansen A/S
17289377 METHOD TO USE INDUSTRIAL CO2 CONTAINING GAS FOR THE PRODUCTION OF A METHANE ENRICHED GAS COMPOSITION Non-Final OA ELECTROCHAEA GMBH
17436893 SELECTION MEDIUM FOR BACTERIA BELONGING TO GENUS PSEUDOMONAS AND USE THEREOF Final Rejection KABUSHIKI KAISHA YAKULT HONSHA
17436892 CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION Final Rejection Obsidian Therapeutics, Inc.
17820921 NON-CALORIC SWEETENERS AND METHODS FOR SYNTHESIZING Final Rejection Conagen Inc.
17609358 NOVEL GARDNERELLA ENDOLYSINS AND USES THEREOF Non-Final OA BioNTech SE
17638837 Method for Measuring Pentosidine and Measurement Kit Non-Final OA Kikkoman Corporation
17611312 COMPOSITION Non-Final OA MORINAGA MILK INDUSTRY CO., LTD.
17772464 RECOMBINANT ACE2-FC FUSION MOLECULES AND METHODS OF MAKING AND USING THEREOF Non-Final OA BAILI-BIO (CHENGDU) PHARMACEUTICAL CO., LTD.
18003018 METHOD FOR PREPARING RECOMBINANT HUMAN EXTRACELLULAR MATRIX STRUCTURAL PROTEIN Final Rejection GuangZhou JiDa Biological Technology Co., Ltd
17278410 PESTICIDAL COMBINATIONS OF YERSINIA AND BACILLUS Final Rejection NOVOZYMES BIOAG A/S
17775253 DEOXYRIBONUCLEASE VARIANTS AND USES THEREOF Non-Final OA THERMO FISHER SCIENTIFIC BALTICS UAB
17638166 Tryptase Activity Measurement Substrate Non-Final OA Peptide Support Co. Ltd.
17559978 METHODS OF PURIFYING CHARGE-SHIELDED FUSION PROTEINS Non-Final OA Pfenex, Inc.
17616968 LACTOBACILLUS COMPOSITIONS AND USES THEREOF Non-Final OA Probi AB
17430071 CHROMATOGRAPHIC PURIFICATION OF AT LEAST ONE ENZYME SELECTED FROM A GROUP INCLUDING COLLAGENASE TYPE I, COLLAGENASE TYPE II, NEUTRAL PROTEASE AND CLOSTRIPAIN Non-Final OA NORDMARK PHARMA GMBH
17383109 METHODS OF PRODUCING AND USING RECOMBINANT ALPHA 1-ANTITRYPSIN (AAT) AND COMPOSITIONS THEREOF Final Rejection EXCELLGENE SA
17416822 METHOD FOR DETECTING AND ENUMERATING OF LOW CONCENTRATIONS OF LISTERIA Final Rejection SENSILIST AS

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month